RE:Another new highThe strength, the chart, the price, the promise. Loving them apples. There simply aren't a lot of free float shares available for a solid and valuable play fo this caliber. $485M/MC and should be yet another acquisition on tap. Medcurrent RR and managements quite obvious robust thinking to me means that they are working toward an overall $100M RR/year mark. Next to impossible to lose to a competitor. Vitalhub is becoming stickier than Spiderman eating candy at Halloween. I feel more than ever that management and insiders believea lofty valuation is in their grasp, via natural evolution of shareholders or a buyout, by doin what they've always been doin. No insiders, including Dan have sold a share (holding 51% majority give or take?) actually the Shens just bought a boatload more on the last offering. Myself included. Following the story, following the buildup, following the money, enjoying the returns...Follow the leader the say. Experts in the field, adopting more and more experts.
Let's go Vital! 7 year dream finally coming to fruition and it's going to last.
#Healthcare #PatientFlow #Solution #Highdemand
Golden